AI in Action E173: Dr. Marion Cornelia Schwarzler, Head of Decision Science & Advanced Analytics for Medical Affairs at Bayer

 | February 9 2021 | Mark Kelly

Welcome to episode 173 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.

Today’s guest is Dr. Marion Cornelia Schwarzler, Head of Decision Science & Advanced Analytics for Medical Affairs, Pharmacovigilance & Regulatory Affairs at Bayer in Berlin. Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Their products and services are designed to benefit people and improve their quality of life while at the same time, they aim to create value through innovation, growth and high earning power.

Bayer’s products help address some of today’s biggest challenges, including global population growth, an ageing society and the need to make efficient and more sustainable use of natural resources. In line with their mission “Bayer: Science For A Better Life,” they aim to improve people’s quality of life by preventing, alleviating or curing diseases. For these endeavours, they focus on developing and successfully commercializing innovative products and solutions based on scientific knowledge.

In the episode, Marion will discuss:

The interesting work they are doing at Bayer

The benefits of applying data science within the Healthcare industry

Challenges needed to overcome such as data privacy and data access

The impact of applying NLP in Healthcare Data

The importance of diversity within data science teams

What the future holds for Data Science within Healthcare

To find out more about Marion and her fantastic work at Bayer Pharmaceuticals, check out the website pharma.bayer.com or follow them on Twitter @BayerPharma. You can also connect with Marion on Linkedin.

What did you think of Marion’s podcast? Where do you see the future of Artificial Intelligence and Data Science in the Healthcare sector heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.

If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.

Subscribe to the AI in Action Podcast:

related podcasts

ServiceNow Series E73: Robert Elliott, VP, ServiceNow Services at Optimum Healthcare IT

Robert Elliott, VP, ServiceNow Services at Optimum Healthcare IT joins host Mark Kelly on the ServiceNow series of The Alldus Podcast to discuss understanding the key problems they solve for customers, stakeholder management, challenges to overcome & use cases of the impact they bring to customers

Read More

ServiceNow Series E72: Oliver Stöckl, VP of EMEA at Brightfin

Oliver Stöckl, VP of EMEA at Brightfin joins host Mark Kelly on the ServiceNow series of The Alldus Podcast to discuss his work with Brightfin, examples of the benefits they bring to customers, defining the most important problems to solve and his advice to people looking at a career in ServiceNow

Read More

ServiceNow Series E71: Richard Groff, Senior ServiceNow Program Manager at Latham & Watkins

Richard Groff, Senior ServiceNow Program Manager at Latham & Watkins joins host Mark Kelly on the ServiceNow series of The Alldus Podcast to discuss the reality of implementing ServiceNow in your business, the importance of team building & talent development, managing your service models/CMDB & more

Read More